OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Gut microbiota modulate distal symmetric polyneuropathy in patients with diabetes
Junpeng Yang, Xueli Yang, Guojun Wu, et al.
Cell Metabolism (2023) Vol. 35, Iss. 9, pp. 1548-1562.e7
Open Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

A core microbiome signature as an indicator of health
Guojun Wu, Ting Xu, Naisi Zhao, et al.
Cell (2024) Vol. 187, Iss. 23, pp. 6550-6565.e11
Open Access | Times Cited: 30

Probiotic Clostridium butyricum ameliorates cognitive impairment in obesity via the microbiota-gut-brain axis
Mingxuan Zheng, Huaiyu Ye, Xiaoying Yang, et al.
Brain Behavior and Immunity (2023) Vol. 115, pp. 565-587
Closed Access | Times Cited: 30

The Next Generation Fecal Microbiota Transplantation: To Transplant Bacteria or Virome
You Yu, Weihong Wang, Faming Zhang
Advanced Science (2023) Vol. 10, Iss. 35
Open Access | Times Cited: 24

Oral-gut microbial transmission promotes diabetic coronary heart disease
Yiwen Li, Yanfei Liu, Jing Cui, et al.
Cardiovascular Diabetology (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 12

Diabetes in China: epidemiology, pathophysiology and multi-omics
Weiping Jia, Juliana C.N. Chan, Tien Yin Wong, et al.
Nature Metabolism (2025)
Closed Access | Times Cited: 1

Gut–X axis
Lin Xu, Yu Zhang, Xueyan Li, et al.
iMeta (2025) Vol. 4, Iss. 1
Open Access | Times Cited: 1

Biomimetic nanoplatform with microbiome modulation and antioxidant functions ameliorating insulin resistance and pancreatic β-cell dysfunction for T2DM management
Xiudan Wang, Rui Tian, Chenghong Liang, et al.
Biomaterials (2024) Vol. 313, pp. 122804-122804
Closed Access | Times Cited: 5

Biochemical Strategy-Based Hybrid Hydrogel Dressing-Mediated In Situ Synthesis of Selenoproteins for DFU Immunity-Microbiota Homeostasis Regulation
Xueling Liu, Weidi Wang, Yali Wang, et al.
Biomaterials (2025) Vol. 317, pp. 123114-123114
Closed Access

Protein-bound uremic toxins as therapeutic targets for cardiovascular, kidney, and metabolic disorders
Shihan Zhang, Shasha Tang, Yalei Liu, et al.
Frontiers in Endocrinology (2025) Vol. 16
Open Access

Probiotics alleviate painful diabetic neuropathy by modulating the microbiota–gut–nerve axis in rats
Ye Jiang, Jing Yang, Min Wei, et al.
Journal of Neuroinflammation (2025) Vol. 22, Iss. 1
Open Access

Embracing Interpersonal Variability of Microbiome in Precision Medicine
Xin Zhou, Xin Chen, Mark M. Davis, et al.
Phenomics (2025)
Closed Access

Dietary Fatty Acid Composition Alters Gut Microbiome in Mice with Obesity-Induced Peripheral Neuropathy
Mohamed Noureldein, Amy E. Rumora, Samuel J. Teener, et al.
Nutrients (2025) Vol. 17, Iss. 4, pp. 737-737
Open Access

Advances in fecal microbiota transplantation for the treatment of diabetes mellitus
Juan Zhang, Honggang Wang, Ying Liu, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 4

Washed microbiota transplantation reduces glycemic variability in unstable diabetes
Yangyang Li, Qing Liu, Lingyu Zhang, et al.
Journal of Diabetes (2023) Vol. 16, Iss. 2
Open Access | Times Cited: 8

Discovery of first-in-class highly selective TRPV1 antagonists with dual analgesic and hypoglycemic effects
Chunxia Liu, Wenxin Wang, Shiyu Zhao, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 107, pp. 117750-117750
Closed Access | Times Cited: 2

Guild-level signature of gut microbiome for diabetic kidney disease
Shasha Tang, Guojun Wu, Yalei Liu, et al.
mBio (2024) Vol. 15, Iss. 7
Open Access | Times Cited: 2

Gut microbiota predict retinopathy in patients with diabetes: A longitudinal cohort study
Xinran Qin, Jiaqi Sun, Shuli Chen, et al.
Applied Microbiology and Biotechnology (2024) Vol. 108, Iss. 1
Open Access | Times Cited: 2

The Potential Hypoglycemic Competence of Low Molecular Weight Polysaccharides Obtained from Laminaria japonica
Aijun Tong, Dengwei Wang, Xiaoyan Liu, et al.
Foods (2023) Vol. 12, Iss. 20, pp. 3809-3809
Open Access | Times Cited: 6

The oral microbial odyssey influencing chronic metabolic disease
U Gupta, Priyankar Dey
Archives of Physiology and Biochemistry (2023), pp. 1-17
Closed Access | Times Cited: 6

Causal effects of gut microbiota on diabetic neuropathy: a two-sample Mendelian randomization study
Ming Xu, Jinxuan Hao, Yijie Qi, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 1

Molecular mechanisms of enteric neuropathies in high‐fat diet feeding and diabetes
Francesca Cingolani, Arun Balasubramaniam, Shanthi Srinivasan
Neurogastroenterology & Motility (2024)
Closed Access | Times Cited: 1

Faecal microbiota transplantation for patients with diabetes type 1 and severe gastrointestinal neuropathy (FADIGAS): a randomised, double-blinded, placebo-controlled trial
Katrine Lundby Høyer, Simon Mark Dahl Baunwall, Ditte Smed Kornum, et al.
EClinicalMedicine (2024) Vol. 79, pp. 103000-103000
Closed Access | Times Cited: 1

Altered gut microbiota in Taiwanese A97S predominant transthyretin amyloidosis with polyneuropathy
Chieh‐Chang Chen, Ping‐Huei Tseng, Hsueh‐Wen Hsueh, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1

Effects of gut microbiome on type 1 diabetes susceptibility and complications: A large‐scale bidirectional Mendelian randomization and external validation study
Keyu Guo, Jianan Ye, Jiaqi Li, et al.
Diabetes Obesity and Metabolism (2024) Vol. 26, Iss. 8, pp. 3306-3317
Closed Access | Times Cited: 1

Page 1 - Next Page

Scroll to top